Listen to Jean-Frédéric’s “fireside chat” recorded during the OIS meeting with Joseph Sullivan, Founder of Emmetropes, to discover:
The progress of Théa Open Innovation that has made implementing licensing agreements and capital investments with early stage partners. The subsidiary has already signed agreements that help advance treatments for myopia, wet and dry age-related macular degeneration and macular edema.
